Skip Navigation

Text From Here.

English Publication 2003

  1. Sato M, Kishi K, Shirai S, Suwa K, Kimura M, Kawai N, Tanihata H, Yamada K, Terada M, Yamaue H: Radiation therapy for a massive arteriovenous malformation of the pancreas. Am J Roentgenol 181(6):1627-8.2003
  2. Uchiyama K, Kawai M, Onishi H, Tani M, Kinoshita H, Ueno M, Yamaue H: Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy. Dig Dis Sci 48(10):1955-9. 2003
  3. Uchiyama K, Nakai T, Tani M, Onishi H, Kinoshita H, Kawai M, Ueno M, Yamaue H: Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch Surg 138(9):1012-6. 2003
  4. Nakamori M, Iwahashi M, Nakamura M, Yamaue H: Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. Surg Oncol 84(1):10-6. 2003
  5. Yamaue H, Tanimura H, Kono N, Aoki Y, Tabuse K, Uchiyama K, Takifuji K, Iwahashi M, Tani M. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer. Anticancer Res 23(3B):2559-64. 2003
  6. Uchiyama K, Onishi H, Tani M, Kinoshita H, Kawai M, Ueno M, Yamaue H.Long-term prognosis after treatment of patients with choledocholithiasis. Ann Surg 238(1):97-102. 2003
  7. Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Clin Cancer Res 9(6):2357-65. 2003
  8. Tsunoda T, Koh Y, Koizumi F, Tsukiyama S, Ueda H, Taguchi F, Yamaue H, Saijo N, Nishio K. Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis. Int J Oncol 23(1):49-59. 2003
  9. Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Ojima T, Yamaue H. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer. Surgery 133(3):309-17, 2003
  10. Shono Y, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Tanaka H, Matsuda K, Yamaue H. Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers. Br J Cancer 88(4):530-6, 2003